Jefferies raises Iovance Biotherapeutics target price to $20 from $12
IOVA•Jefferies raised its target price for Iovance Biotherapeutics to $20 from $12.
Related News
SoFi Technologies receives StoneX buy rating with $25 price target
SOFI•
Canaccord Genuity raises First Tracks Biotherapeutics target price to $60 from $50
TRAX•
JPMorgan cuts Duke Energy target price to $130 from $137
DUK•
DXC partners with LangChain to expand agentic AI for mission-critical IT operations
DXC•
Japan's Nikkei slides as AI stocks tumble, geopolitical risks weigh
EWJ•